Metastastic Breast Cancer: Clinical Trials

2 trials for Metastastic Breast Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Terminated 1

Follow Metastastic Breast Cancer: new trials by email Literature Review of Metastastic Breast Cancer trials Research Report on Metastastic Breast Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Culmerciclib in HR+/HER2+ Advanced Breast Cancer
Culmerciclib - Breast Cancer, Metastastic Breast Cancer
Phase 2RecruitingSun Yat-sen University352026-08-012026-07-29
Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer
Gemcitabine and oxaliplatin - Recurrent Breast Cancer, Metastastic Breast Cancer
Phase 2TerminatedUniversity of Southern California72003-07-012014-05-22

Narrower conditions

Breast Neoplasms (2)

Broader conditions

Breast Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

Gemcitabine (1)  ·  Oxaliplatin (1)

Sponsors

Sun Yat-sen University (1)  ·  University of Southern California (1)

Countries

China (1)  ·  United States (1)

Top investigators

Christy Russell, MD (1)